Moderna's influenza vaccine superior to licensed shot in study-February 2024-www.financetom.com

Moderna's influenza vaccine superior to licensed shot in study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Moderna's influenza vaccine superior to licensed shot in study

Jun 30, 2025 4:37 AM

June 30 (Reuters) - Moderna ( MRNA ) said its

experimental influenza vaccine showed superior efficacy,

compared with a licensed standard-dose seasonal flu shots in

adults aged 50 years and older in a late-stage study.

Previous page： BRIEF-Callan Jmb Inc. Adds As Paulson Investment Company, Llc As The Underwriter Of IPO- SEC Filing Next page： Gitlab Insider Sold Shares Worth $4,984,750, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-Callan Jmb Inc. Adds As Paulson Investment Company, Llc As The Underwriter Of IPO- SEC Filing

Dec 17, 2024

Dec 17 (Reuters) - * CALLAN JMB INC. ADDS AS PAULSON INVESTMENT COMPANY, LLC AS THE UNDERWRITER OF IPO- SEC FILING Source text: Further company coverage: [ ] ...

Gitlab Insider Sold Shares Worth $4,984,750, According to a Recent SEC Filing

Dec 17, 2024

05:47 PM EST, 12/17/2024 (MT Newswires) -- Sytse Sijbrandij, 10% Owner, Director, on December 16, 2024, sold 84,000 shares in Gitlab ( GTLB ) for $4,984,750. SEC Filing: https://www.sec.gov/Archives/edgar/data/1653482/000162828024051741/xslF345X05/wk-form4_1734475422.xml ...

Webuy Global Closes $3.7 Million Stock Offering; Shares Rise After Hours

Dec 17, 2024

05:42 PM EST, 12/17/2024 (MT Newswires) -- Webuy Global ( WBUY ) said late Tuesday it closed a registered direct offering of about 21 million class A ordinary shares at $0.1756 apiece for about $3.7 million in estimated gross proceeds. The company's shares were up more than 4% in after-hours activity. ...

Bain's $1.7 bln offer rebuffed by Australia's Insignia on valuation concerns

Dec 17, 2024

Dec 18 (Reuters) - Australia's Insignia Financial ( IOOFF ) has rejected Bain Capital's A$2.67 billion ($1.69 billion) takeover bid, saying the offer does not provide fair value to its shareholders, creating a barrier for the buyout giant's Asia expansion plans. Bain had earlier in the month offered A$4 apiece for the 178-year-old money manager, reigniting a strong sense of...